Australian players can enjoy colourful slots, immersive reels, and interactive bonuses while spinning at King Johnnie, creating a fun online adventure.

Casino Mate Australia provides fast spins, rewarding promotions, and engaging reels, giving Australian punters a lively and dynamic gaming experience.

Spinrise Casino delivers vibrant gameplay, interactive features, and exciting rewards, allowing Australian audiences to enjoy a smooth and thrilling session at Spinrise Casino.

Wild Fortune Casino brings immersive slots, engaging reels, and rewarding bonuses, giving Australian players an exciting and lively online experience on Wild Fortune Casino.

Explore colourful reels, claim interactive promotions, and enjoy smooth gameplay while playing at King Billy, creating a thrilling adventure for Australian audiences.

Ricky Casino Australia offers immersive reels, fast spins, and rewarding bonuses, letting Australian players enjoy a fun and engaging online session at Ricky Casino Australia.

Spin exciting slots, claim interactive rewards, and explore immersive gameplay while playing at RipperCasino, giving Australian punters a lively experience.

Joe Fortune Casino provides engaging reels, vibrant slots, and rewarding promotions, allowing Australian players to enjoy smooth gameplay and a dynamic adventure on Joe Fortune Casino.

Amanta Healthcare Limited, a pharmaceutical company engaged in development, manufacturing, and marketing of sterile liquid products, including both large and small volume parenterals (LVPs and SVPs), proposes to open its Initial Public Offering on September 01, 2025, aiming to raise ₹ 12,600.00 Lakhs (at upper price band) with shares to be listed on the NSE and BSE Platform.

The issue size is up to 1,00,00,000 equity shares with a face value of ₹ 10 each with a price band of ₹ 120 – ₹ 126 Per Equity Share.


  • Issue Opens: September 1, 2025
  • Issue Closes: September 3, 2025
  • Face Value: Rs 10 each
  • Price Band: Rs 120 – 126 per share
  • Lot Size: 119 Shares
  • Listing: BSE & NSE

The net proceeds from the IPO will be utilized for funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat, funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat, and general corporate purposes. The anchor portion will open on Friday, August 29, 2025 and issue will close on Wednesday, September 03, 2025.

Amanta Healthcare Limited, a pharmaceutical company engaged in developing, manufacturing, and marketing of sterile liquid products, including both large and small volume parenterals (LVPs and SVPs) using Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies, The Company serve’s six therapeutic segments such as fluid therapy – (IV Fluid), formulations, diluents, ophthalmic, respiratory care and irrigation solutions.

The company also manufacture medical devices like irrigation solutions, first-aid products, and eye lubricants. Our packaging includes a wide range of closure systems and container volumes from 2 ml to 1000 ml. In FY25, The Company achieved a Revenue of ₹ 27,470.82 Lakhs, EBITDA of ₹ 6,105.37 Lakhs & PAT of ₹ 1,050.07 Lakhs

About the author: IE&M Team
Picture of IE&M Team
Indian Economy & Market is an Indian media and information platform producing data-backed news and analysis on all the vital elements at the intersection of the economy, stock markets, mutual fund, insurance, commodities, currency, technology, startups and business.

More articles by the author

Table of Contents